Line Claude
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Line Claude has a total of 254 co-authors. Here are the top co-authors by number of shared publications:
C. Carrie
Centre Léon Bérard, Radiotherapy Department, Lyon, France
7 shared publications- Anne Laprie
Department of Radiation Oncology, University Institute of Cancer Toulouse-Oncopôle , Toulouse
6 shared publications A. Laprie
Service d'oncologie-radiothérapie, Institut universitaire du cancer de Toulouse-Oncopole, Toulouse, France
5 shared publications- Perrine Marec-Berard
Centre Léon Bérard, Lyon, France
5 shared publications - Christian Carrie
Radiotherapy Department, Léon Bérard Center, Lyon, France; CNRS UMR 5220, INSERM U1044, INSA, University of Lyon, Lyon, France
4 shared publications S. Supiot
Département De Radiothérapie, Institut De Cancérologie De L'ouest, Nantes-Saint Herblain, France
4 shared publications
Latest Publications
- Open Access
- 9 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111567
Dose-dependent cerebrovascular impact of pediatric brain radiotherapy revealed by advanced MRI: the AVARTHEC study
- 9 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111567
Open AccessDose-dependent cerebrovascular impact of pediatric brain radiotherapy revealed by advanced MRI: the AVARTHEC study
- 15 October 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (7-8) , 104756
Guide for paediatric radiotherapy procedures: 2025 update
- 15 October 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (7-8) , 104756
Guide for paediatric radiotherapy procedures: 2025 update
- Open Access
- 6 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (4) , e32012
Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series
Background and Purpose: Ewing sarcoma (ES) is the most prevalent malignant thoracic tumor in childhood and young adults. This study reports the outcome of a national cohort treated in an international prospective trial for a localized rib ES, with a long follow‐up. Material and Methods: All the patients treated in a prospective trial (December 1999–April 2013) were included. Data were collected from a prospective database and supplemented by a retrospective review of the patients’ files. Local control alone rate, progression‐free survival (PFS), and overall survival (OS) were assessed. Multivariate analyses were conducted to adjust for classical prognosis factors. Results: Eighty‐two patients, median age 13.6 years, were included. All received induction chemotherapy. Surgery was completed (R0) in 88%. Overall, 66% had good histological response (GR). Radiotherapy (RT) was performed on the primary tumor in 28%, on the hemithorax in 13%, or on both in 32%. With a median follow‐up of 12 years, 28 patients (34%) relapsed. Five‐year local control rate was 95% (95%CI [89%–95%]), 5‐year PFS was 73% (95%CI [62%–81%]), and 5‐year OS was 79% (95%CI [69%–87%]). In multivariate analysis, pleural effusion was significantly associated with poor PFS ( p = 0.049). In the case of R0 and GR ( n = 41), no significant difference in PFS/OS ( p = 0.16/ p = 0.36) was reported according to adjuvant local RT. Overall, 38% of scoliosis and 7.3% of secondary cancer were reported. Conclusion: A multidisciplinary approach in high‐risk patients can provide good local control in rib ES. In patients who have undergone R0 surgery and are GR, omitting adjuvant RT of the surgical bed may be discussed.
- 6 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (4) , e32012
Open AccessRib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series
Background and Purpose: Ewing sarcoma (ES) is the most prevalent malignant thoracic tumor in childhood and young adults. This study reports the outcome of a national cohort treated in an international prospective trial for a localized rib ES, with a long follow‐up. Material and Methods: All the patients treated in a prospective trial (December 1999–April 2013) were included. Data were collected from a prospective database and supplemented by a retrospective review of the patients’ files. Local control alone rate, progression‐free survival (PFS), and overall survival (OS) were assessed. Multivariate analyses were conducted to adjust for classical prognosis factors. Results: Eighty‐two patients, median age 13.6 years, were included. All received induction chemotherapy. Surgery was completed (R0) in 88%. Overall, 66% had good histological response (GR). Radiotherapy (RT) was performed on the primary tumor in 28%, on the hemithorax in 13%, or on both in 32%. With a median follow‐up of 12 years, 28 patients (34%) relapsed. Five‐year local control rate was 95% (95%CI [89%–95%]), 5‐year PFS was 73% (95%CI [62%–81%]), and 5‐year OS was 79% (95%CI [69%–87%]). In multivariate analysis, pleural effusion was significantly associated with poor PFS ( p = 0.049). In the case of R0 and GR ( n = 41), no significant difference in PFS/OS ( p = 0.16/ p = 0.36) was reported according to adjuvant local RT. Overall, 38% of scoliosis and 7.3% of secondary cancer were reported. Conclusion: A multidisciplinary approach in high‐risk patients can provide good local control in rib ES. In patients who have undergone R0 surgery and are GR, omitting adjuvant RT of the surgical bed may be discussed.
- 17 March 2025
- Published by Elsevier in Bulletin du Cancer
- Vol. 112 (6) , 656-663
Radiothérapie des sarcomes d’Ewing
- 17 March 2025
- Published by Elsevier in Bulletin du Cancer
- Vol. 112 (6) , 656-663
Radiothérapie des sarcomes d’Ewing
- Open Access
- 31 May 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (6) , 3177-3188
Fertility Assessment after Ovarian Transposition in Children and Young Women Treated for a Malignant Tumor
Ovarian transposition (OT) has been proposed as a protective measure against radiation-induced damage to ovarian function and fertility. Despite its historical use, limited research has focused on evaluating endocrine and exocrine ovarian function after OT performed in adolescents and young adults (AYAs) before or during puberty. The purpose of our study was to investigate the fertility, pubertal development, and ovarian function of women with a previous history of OT during childhood, adolescence or young adulthood. In an observational bicentric retrospective study, we included 32 young female cancer patients who underwent OT before the age of 26 between 1990 and 2015 at Lyon Léon Bérard Cancer Center or Nancy University Hospital. The mean age at the time of OT was 15.6 years with a cancer diagnosis at 15 ± 4.8 years. Among the 10 women attempting pregnancy post-treatment, 60% achieved successful pregnancies. After a mean follow-up of 9.6 ± 7 years, 74% (17 out of 23) of women recovered spontaneous menstrual cycles (seven out of eight evaluable women with OT before or during puberty). Notably, 35% of women who did not attempt pregnancy demonstrated adequate ovarian reserve. Ovarian reserve and function recovery were influenced by the specific chemotherapy received. Importantly, our findings suggest that OT’s effectiveness on ovarian activity resumption does not significantly differ when performed before or during puberty compared to pubertal stages. This study contributes valuable insights into the long-term reproductive outcomes of young women undergoing OT, emphasizing its potential efficacy in preserving ovarian function and fertility across different developmental stages.
- 31 May 2024
- Published by MDPI AG in Current Oncology
- Vol. 31 (6) , 3177-3188
Open AccessFertility Assessment after Ovarian Transposition in Children and Young Women Treated for a Malignant Tumor
Ovarian transposition (OT) has been proposed as a protective measure against radiation-induced damage to ovarian function and fertility. Despite its historical use, limited research has focused on evaluating endocrine and exocrine ovarian function after OT performed in adolescents and young adults (AYAs) before or during puberty. The purpose of our study was to investigate the fertility, pubertal development, and ovarian function of women with a previous history of OT during childhood, adolescence or young adulthood. In an observational bicentric retrospective study, we included 32 young female cancer patients who underwent OT before the age of 26 between 1990 and 2015 at Lyon Léon Bérard Cancer Center or Nancy University Hospital. The mean age at the time of OT was 15.6 years with a cancer diagnosis at 15 ± 4.8 years. Among the 10 women attempting pregnancy post-treatment, 60% achieved successful pregnancies. After a mean follow-up of 9.6 ± 7 years, 74% (17 out of 23) of women recovered spontaneous menstrual cycles (seven out of eight evaluable women with OT before or during puberty). Notably, 35% of women who did not attempt pregnancy demonstrated adequate ovarian reserve. Ovarian reserve and function recovery were influenced by the specific chemotherapy received. Importantly, our findings suggest that OT’s effectiveness on ovarian activity resumption does not significantly differ when performed before or during puberty compared to pubertal stages. This study contributes valuable insights into the long-term reproductive outcomes of young women undergoing OT, emphasizing its potential efficacy in preserving ovarian function and fertility across different developmental stages.
- 26 October 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (8) , 736-745
Caractéristiques de la radiothérapie chez les adolescents et les jeunes adultes
- 26 October 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (8) , 736-745
Caractéristiques de la radiothérapie chez les adolescents et les jeunes adultes
- 24 August 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (1) , 131-140
Radiotherapy management of paediatric cancers with synchronous metastasis
- 24 August 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (1) , 131-140
Radiotherapy management of paediatric cancers with synchronous metastasis
- Open Access
- 14 August 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (11) , e30627
Post‐operative flank irradiation using conformal versus highly conformal radiotherapy techniques for paediatric renal tumours: Results from the French registry PediaRT
Purpose: Three‐dimensional conformal RT (3D‐RT) techniques are gold standard for post‐operative flank radiotherapy (RT) in paediatric renal tumours. Recently, highly conformal RT (HC‐RT) techniques have been implemented without comparative clinical data. The main objective of this multicentre study was to compare locoregional control (LRC) in children treated either with HC‐RT or 3D‐RT techniques.Methods: Patients treated with post‐operative flank RT for renal tumour registered in the national cohort PediaRT between March 2013 and September 2019 were included. Treatment and follow‐up data, including toxicities and outcomes, were retrieved from the database. LRC was calculated, and dose reconstruction was performed in case of an event.Results: Seventy‐nine patients were included. Forty patients were treated with HC‐RT and 39 with 3D‐RT. Median follow‐up was 4.5 years. Three patients had locoregional failure (LRF; 4%). HC‐RT was not associated with a higher risk of LRF. Three‐year LRC were 97.4% and 94.7% in the HC‐RT and 3D‐RT groups, respectively. The proportion of planning target volumes receiving 95% or more of the prescribed dose did not significantly differ between both groups (HC‐RT 88%; 3D‐RT 69%; p = .05). HC‐RT was better achieving dose constraints, and a significant mean dose reduction was observed in the peritoneal cavity and pancreas associated with lower incidence of acute gastrointestinal toxicity.Conclusion: LRF after post‐operative flank RT for renal tumours was rare and did not increase using HC‐RT versus 3D‐RT techniques. Dose to the pancreas and the peritoneal cavity, as well as acute toxicity, were reduced with HC‐RT compared to 3D‐RT.
- 14 August 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (11) , e30627
Open AccessPost‐operative flank irradiation using conformal versus highly conformal radiotherapy techniques for paediatric renal tumours: Results from the French registry PediaRT
Purpose: Three‐dimensional conformal RT (3D‐RT) techniques are gold standard for post‐operative flank radiotherapy (RT) in paediatric renal tumours. Recently, highly conformal RT (HC‐RT) techniques have been implemented without comparative clinical data. The main objective of this multicentre study was to compare locoregional control (LRC) in children treated either with HC‐RT or 3D‐RT techniques.Methods: Patients treated with post‐operative flank RT for renal tumour registered in the national cohort PediaRT between March 2013 and September 2019 were included. Treatment and follow‐up data, including toxicities and outcomes, were retrieved from the database. LRC was calculated, and dose reconstruction was performed in case of an event.Results: Seventy‐nine patients were included. Forty patients were treated with HC‐RT and 39 with 3D‐RT. Median follow‐up was 4.5 years. Three patients had locoregional failure (LRF; 4%). HC‐RT was not associated with a higher risk of LRF. Three‐year LRC were 97.4% and 94.7% in the HC‐RT and 3D‐RT groups, respectively. The proportion of planning target volumes receiving 95% or more of the prescribed dose did not significantly differ between both groups (HC‐RT 88%; 3D‐RT 69%; p = .05). HC‐RT was better achieving dose constraints, and a significant mean dose reduction was observed in the peritoneal cavity and pancreas associated with lower incidence of acute gastrointestinal toxicity.Conclusion: LRF after post‐operative flank RT for renal tumours was rare and did not increase using HC‐RT versus 3D‐RT techniques. Dose to the pancreas and the peritoneal cavity, as well as acute toxicity, were reduced with HC‐RT compared to 3D‐RT.
- 14 November 2022
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 114 (5) , 1074-1075
Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: results of a national prospective multicenter study
- 14 November 2022
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 114 (5) , 1074-1075
Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: results of a national prospective multicenter study